Casdin Capital’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-75,000
| Closed | -$5.85M | – | 61 |
|
|
2021
Q2 | $5.85M | Hold |
75,000
| – | – | 0.15% | 48 |
|
|
2021
Q1 | $7.09M | Hold |
75,000
| – | – | 0.21% | 42 |
|
|
2020
Q4 | $9.14M | Hold |
75,000
| – | – | 0.27% | 42 |
|
|
2020
Q3 | $6.55M | Hold |
75,000
| – | – | 0.29% | 41 |
|
|
2020
Q2 | $4.84M | Hold |
75,000
| – | – | 0.29% | 39 |
|
|
2020
Q1 | $3.35M | Hold |
75,000
| – | – | 0.36% | 37 |
|
|
2019
Q4 | $4.67M | Hold |
75,000
| – | – | 0.43% | 29 |
|
|
2019
Q3 | $2.82M | Buy |
75,000
+15,000
| +25% | +$564K | 0.29% | 32 |
|
|
2019
Q2 | $2.44M | Buy |
+60,000
| New | +$2.44M | 0.23% | 30 |
|